...
首页> 外文期刊>Bone marrow transplantation >Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide.
【24h】

Acquired pseudocholinesterase deficiency after high-dose cyclophosphamide.

机译:大剂量环磷酰胺后获得性伪胆碱酯酶缺乏症。

获取原文
获取原文并翻译 | 示例
           

摘要

Succinylcholine, a depolarizing neuromuscular blocking agent used in anesthesia is hydrolyzed in the plasma by the enzyme pseudocholinesterase (PSC). Conditions associated with reduced PSC activity lead to sustained action of succinylcholine and result in prolonged apnea. Cyclophosphamide is an inhibitor of PSC and its suppressive effect may be dose-dependent. We report a case of severe PSC deficiency after high-dose cyclophosphamide at 7 g/m2. The patient received succinylcholine during anesthesia 9 h after chemotherapy and developed prolonged apnea. This case highlights the potential risk of drug-induced PSC deficiency and cautions the use of depolarizing muscular relaxants soon after high-dose cyclophosphamide.
机译:琥珀酰胆碱是麻醉中使用的去极化神经肌肉阻滞剂,在血浆中被伪胆碱酯酶(PSC)水解。与PSC活性降低相关的疾病会导致琥珀酰胆碱的持续作用并导致呼吸暂停延长。环磷酰胺是PSC的抑制剂,其抑制作用可能与剂量有关。我们报告了在7 g / m2大剂量环磷酰胺后出现严重PSC缺乏症的情况。患者在化疗后9小时麻醉期间接受了琥珀酰胆碱,并出现了长期呼吸暂停。该病例突出了药物引起的PSC缺乏的潜在风险,并提醒在大剂量环磷酰胺治疗后立即使用去极化的肌肉松弛剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号